UTAH MEDICAL PRODUCTS, INC. (UTMD) Free cash flow 2016–2025
UTAH MEDICAL PRODUCTS, INC. (UTMD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$14.3MFY2025 · since FY2016: $11.2M → $14.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $14.3M | -1.9% |
| FY2024 | $14.6M | -32.5% |
| FY2023 | $21.6M | +6.4% |
| FY2022 | $20.3M | -1.5% |
| FY2021 | $20.7M | +7.1% |
| FY2020 | $19.3M | +16.7% |
| FY2019 | $16.5M | +0.5% |
| FY2018 | $16.4M | +7.3% |
| FY2017 | $15.3M | +36.3% |
| FY2016 | $11.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More UTMD financial trends
UTMD RevenueUTMD Net incomeUTMD Net marginUTMD Gross profitUTMD Gross marginUTMD Operating incomeUTMD Operating marginUTMD Operating cash flowUTMD Capital expendituresUTMD Return on equityUTMD Stock buybacksUTMD Dividends paidUTMD Total assetsUTMD Total liabilitiesUTMD Shareholders’ equityUTMD overview →